Home
/
Bone Biologics Corp
/
Financials
/
Quarterly
Bone Biologics Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Bone Biologics Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2021
Jun 30, 2021
$1.07B
Aug 16, 2021
Q1
2021
Mar 31, 2021
$1.07B
May 21, 2021
Q3
2020
Sep 30, 2020
$1.07B
Apr 15, 2021
Q2
2020
Jun 30, 2020
$1.07B
Apr 15, 2021
Q1
2020
Mar 31, 2020
$1.07B
Apr 15, 2021
Q1
2019
Mar 31, 2019
$1.07B
May 14, 2019
Q3
2018
Sep 30, 2018
$1.07B
Nov 16, 2018
Q2
2018
Jun 30, 2018
$1.07B
Aug 14, 2018
Q1
2018
Mar 31, 2018
$1.07B
May 15, 2018
Q2
2017
Dec 31, 2016
$1.07B
Aug 8, 2017
Q3
2017
Dec 31, 2016
$1.07B
Nov 14, 2017
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($666.7K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($740.5K)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($740.5K)
Nov 14, 2025
Q3
2025
Mar 31, 2025
($1.02M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($1.02M)
May 12, 2025
Q2
2025
Mar 31, 2025
($1.02M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($941.0K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($783.7K)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($783.7K)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($866.0K)
May 12, 2025
Q3
2025
Mar 31, 2024
($866.0K)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($866.0K)
Aug 14, 2025
Q3
2024
Sep 30, 2023
($1.92M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.77M)
Aug 9, 2024
Q3
2024
Jun 30, 2023
($1.77M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($3.71M)
May 14, 2024
Q2
2024
Mar 31, 2023
($3.71M)
Aug 9, 2024
Q3
2024
Mar 31, 2023
($3.71M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($1.22M)
Nov 14, 2023
Q3
2023
Jun 30, 2022
($469.3K)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($715.3K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($748.1K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.04M)
May 12, 2025
Q3
2025
Sep 30, 2024
($951.0K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($809.7K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($903.5K)
May 12, 2025
Q3
2024
Sep 30, 2023
($2.08M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($3.04M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($3.15M)
May 14, 2024
Q3
2023
Sep 30, 2022
($1.22M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($469.3K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($689.5K)
May 15, 2023
Q3
2022
Sep 30, 2021
($229.8K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($231.9K)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($180.9K)
May 13, 2022
Q3
2021
Sep 30, 2020
($145.8K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($132.7K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($340.1K)
May 21, 2021
Q3
2020
Sep 30, 2019
($301.3K)
Apr 15, 2021
Q2
2020
Jun 30, 2019
($679.3K)
Apr 15, 2021